Company intelligence / Profile preview

SILAB

Saint-Viance, Nouvelle-Aquitaine, France

Ownership: Private
Development stage: Other

Overview

SILAB is a leading French independent biotech specializing in the engineering of natural active ingredients from plants and microorganisms. Its portfolio includes over 100 scientifically validated cosmetic actives used globally by beauty brands. The company is recognized for its innovation in biotechnology—20% of its sales now come from biotech-derived actives—and unique delivery technologies like biodegradable dry films. It does not develop pharmaceuticals but focuses on healthy and compromised skin through dermo-cosmetic solutions.

Modalities: BiologicRecombinant proteinPeptides
Industry: Non-Drug Biotech

Partnerships

INRA (French National Institute of Agronomic Research) – R&D collaboration on microbiota-derived actives

Beyond the preview

Go deeper on SILAB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SILAB.

Explore the full profile